Biotricity Inc
OTC:BTCY
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Biotricity Inc
OTC:BTCY
|
9.1m USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
33.2B USD |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
18.5B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
7.1B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
41.7B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.6B USD |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
23.7B CNY |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
282.4B INR |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Biotricity Inc
Glance View
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Biotricity Inc is -39.7%, which is above its 3-year median of -138.4%.
Over the last 3 years, Biotricity Inc’s Net Margin has increased from -369.1% to -39.7%. During this period, it reached a low of -369.1% on May 30, 2022 and a high of -39.7% on Jul 30, 2025.
